Save your place

Sign in to WhoBought

Please try again later.

AbbVie Inc. (ABBV) institutional ownership

Latest close $253.30 Jul 22, 2026
Market cap$401.5B 52-week range SectorHealthcare
Funds holding · Q1 2026
3,771
reported ABBV position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net sold $3.1B
1,888 buyers · 1,883 sellers

AbbVie Inc. (ABBV) price and institutional activity

Dates

Q1 2026

$16.9B bought by 1888 investors
Fisher Asset Management, LLC$1.9BCapital Research Global Investors$1.3B +1,886 more
$20.0B sold by 1883 investors
Norges-$5.7BSchwab-$2.7B +1,881 more
Bought Sold Totals per quarter; hover a bar for the names.

AbbVie Inc. (ABBV) institutional activity · 3,771

Investor Type Est. change Change Δ Own Date
Norges · Exited −$5.7B
Change −25.7M Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −$5.7B −25.7M −100.0% Q1 2026
Schwab · Reduced −$2.7B
Change −12.2M Date Q1 2026
Schwab Reduced· Q1 2026 −$2.7B −12.2M Q1 2026
Fisher Asset Management, LLC Added· Q1 2026 +$1.9B +8.5M +1347.0% Q1 2026
Wellington Management Group LLP · Reduced −$1.8B
Change −8.0M Δ Own −53.8% Date Q1 2026
Wellington Management Group LLP Reduced· Q1 2026 −$1.8B −8.0M −53.8% Q1 2026
Dz Bank AG Deutsche Zentral Genossenschafts Bank, Frankfurt AM Main · Reduced −$1.7B
Change −7.8M Date Q1 2026
Dz Bank AG Deutsche Zentral Genossenschafts Bank, Frankfurt AM Main Reduced· Q1 2026 −$1.7B −7.8M Q1 2026
Capital Research Global Investors · Added +$1.3B
Change +5.8M Δ Own +23.0% Date Q1 2026
Capital Research Global Investors Added· Q1 2026 +$1.3B +5.8M +23.0% Q1 2026
JPMorgan Chase & Co · Added +$964M
Change +4.3M Date Q1 2026
JPMorgan Chase & Co Added· Q1 2026 +$964M +4.3M Q1 2026
Diamant Asset Management, Inc. · Added +$811M
Change +3.7M Date Q1 2026
Diamant Asset Management, Inc. Added· Q1 2026 +$811M +3.7M Q1 2026
UBS Group AG · Added +$782M
Change +3.5M Date Q1 2026
UBS Group AG Added· Q1 2026 +$782M +3.5M Q1 2026
T. Rowe Price Associates · Added +$705M
Change +3.2M Date Q1 2026
T. Rowe Price Associates Added· Q1 2026 +$705M +3.2M Q1 2026
Capital World Investors · Added +$614M
Change +2.8M Date Q1 2026
Capital World Investors Added· Q1 2026 +$614M +2.8M Q1 2026
Capital International Investors · Added +$605M
Change +2.7M Date Q1 2026
Capital International Investors Added· Q1 2026 +$605M +2.7M Q1 2026
Nuveen, LLC · Added +$556M
Change +2.5M Date Q1 2026
Nuveen, LLC Added· Q1 2026 +$556M +2.5M Q1 2026
Vanguard · Added +$492M
Change +2.2M Date Q1 2026
Vanguard Added· Q1 2026 +$492M +2.2M Q1 2026
Goldman Sachs Group Inc · Added +$477M
Change +2.1M Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +$477M +2.1M Q1 2026
Data through Q1 2026 · filed Jun 11, 2026
15 of 3771

Famous investor activity in AbbVie Inc. (ABBV)

AbbVie Inc. (ABBV) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Rapp Edward J. · Director Grant (A) $34K
Price $251.64 Qty 134 Owned 29K Trade date Jun 30, 2026 Filed date Jul 2, 2026
Rapp Edward J. Director Grant (A) $251.64 134 $34K 29K Jun 30, 2026 Jul 2, 2026
Quaggin Susan E. · Director Grant (A) $16K
Price $251.64 Qty 62 Owned 853 Trade date Jun 30, 2026 Filed date Jul 2, 2026
Quaggin Susan E. Director Grant (A) $251.64 62 $16K 853 Jun 30, 2026 Jul 2, 2026
Quaggin Susan E. · Director Grant (A) $15K
Price $217.49 Qty 71 Owned 784 Trade date Mar 31, 2026 Filed date Apr 2, 2026
Quaggin Susan E. Director Grant (A) $217.49 71 $15K 784 Mar 31, 2026 Apr 2, 2026
Rapp Edward J. · Director Grant (A) $34K
Price $217.49 Qty 155 Owned 29K Trade date Mar 31, 2026 Filed date Apr 2, 2026
Rapp Edward J. Director Grant (A) $217.49 155 $34K 29K Mar 31, 2026 Apr 2, 2026
Alpern Robert J. · Director Grant (A) $8K
Price $217.49 Qty 35 Owned 10K Trade date Mar 31, 2026 Filed date Apr 2, 2026
Alpern Robert J. Director Grant (A) $217.49 35 $8K 10K Mar 31, 2026 Apr 2, 2026
Purdue David Ryan · Officer Sell −$1.2M
Price $233.56 Qty −5K Owned 3K Trade date Mar 4, 2026 Filed date Mar 6, 2026
Purdue David Ryan Officer Sell $233.56 −5K −$1.2M 3K Mar 4, 2026 Mar 6, 2026
Siatis Perry C. · Officer 3 operations −$4.4M
Price $233.51–$235.26 Qty −19K Owned 5K Trade date Mar 2, 2026 Filed date Mar 3, 2026
Siatis Perry C. Officer 3 operations $233.51–$235.26 −19K −$4.4M 5K Mar 2, 2026 Mar 3, 2026
Crum Demetris D. · Officer Tax withholding or exercise payment (F) -$370K
Price $232.08 Qty -2K Owned 8K Trade date Feb 27, 2026 Filed date Mar 6, 2026
Crum Demetris D. Officer Tax withholding or exercise payment (F) $232.08 -2K -$370K 8K Feb 27, 2026 Mar 6, 2026
Thakkar Roopal · Officer Tax withholding or exercise payment (F) -$1.9M
Price $232.08 Qty -8K Owned 52K Trade date Feb 27, 2026 Filed date Mar 3, 2026
Thakkar Roopal Officer Tax withholding or exercise payment (F) $232.08 -8K -$1.9M 52K Feb 27, 2026 Mar 3, 2026
Michael Robert A. · Director Tax withholding or exercise payment (F) -$8.5M
Price $232.08 Qty -37K Owned 179K Trade date Feb 27, 2026 Filed date Mar 3, 2026
Michael Robert A. Director Tax withholding or exercise payment (F) $232.08 -37K -$8.5M 179K Feb 27, 2026 Mar 3, 2026
Stewart Jeffrey Ryan · Officer Tax withholding or exercise payment (F) -$5.5M
Price $232.08 Qty -24K Owned 83K Trade date Feb 27, 2026 Filed date Mar 3, 2026
Stewart Jeffrey Ryan Officer Tax withholding or exercise payment (F) $232.08 -24K -$5.5M 83K Feb 27, 2026 Mar 3, 2026
Siatis Perry C. · Officer Tax withholding or exercise payment (F) -$3.4M
Price $232.08 Qty -15K Owned 23K Trade date Feb 27, 2026 Filed date Mar 3, 2026
Siatis Perry C. Officer Tax withholding or exercise payment (F) $232.08 -15K -$3.4M 23K Feb 27, 2026 Mar 3, 2026
Reents Scott T. · CFO Tax withholding or exercise payment (F) -$5.0M
Price $232.08 Qty -22K Owned 39K Trade date Feb 27, 2026 Filed date Mar 3, 2026
Reents Scott T. CFO Tax withholding or exercise payment (F) $232.08 -22K -$5.0M 39K Feb 27, 2026 Mar 3, 2026
Purdue David Ryan · Officer Tax withholding or exercise payment (F) -$625K
Price $232.08 Qty -3K Owned 8K Trade date Feb 27, 2026 Filed date Mar 3, 2026
Purdue David Ryan Officer Tax withholding or exercise payment (F) $232.08 -3K -$625K 8K Feb 27, 2026 Mar 3, 2026
Saleki-Gerhardt Azita · Officer Tax withholding or exercise payment (F) -$3.8M
Price $232.08 Qty -16K Owned 198K Trade date Feb 27, 2026 Filed date Mar 3, 2026
Saleki-Gerhardt Azita Officer Tax withholding or exercise payment (F) $232.08 -16K -$3.8M 198K Feb 27, 2026 Mar 3, 2026
15 of 36
15 of 36 Sign in to continue to older insider transactions.

AbbVie Inc. (ABBV) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Vanguard Group Inc 160.4M
% of shares outstanding 9.1% Filing date Feb 13, 2024
Vanguard Group Inc 160.4M 9.1% Feb 13, 2024
BlackRock Inc. 143.2M
% of shares outstanding 8.1% Filing date Jan 25, 2024
BlackRock Inc. 143.2M 8.1% Jan 25, 2024
Vanguard Capital Management LLC 132.9M
% of shares outstanding 7.5% Filing date Apr 29, 2026
Vanguard Capital Management LLC 132.9M 7.5% Apr 29, 2026
3 of 3

AbbVie Inc. (ABBV) ownership FAQ

Who owns ABBV?

3,771 reporting institutions disclosed ABBV position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.